Riskpilot← Back to searchSign inGet full accessLBN MEDICAL ApS
APSActiveCVR 27098290Gugvej 70Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200352 employees
Revenue 2024
DKK 47,4M
0% vs 2023
EBITDA margin
31.8%
+6% vs 2023
Equity ratio
56.2%
Financial strength
Net profit 2024
DKK 10M
+6% vs 2023
| Revenue | DKK 47,4M | +0% |
| EBITDA | DKK 15,1M | +6% |
| Net profit | DKK 10M | +6% |
| Total assets | DKK 77,8M | +11% |
| Equity | DKK 43,7M | +30% |
| Employees | 52 | — |
Legal name
LBN MEDICAL ApS
CVR number
27098290
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. april 2003
Share capital
DKK 6.000.000
Employees
52 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med formanden af bestyrelsen eller af to medlemmer af bestyrelsen i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at handle med medicinsk udstyr og dermed beslægtet virksomhed.
Address
Gugvej 70
Phone
+4596886500
Email
info@lbnmedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 33.078 | 43.514 | 44.571 | 47.147 | 47.353 |
| Staff expenses | -27.547 | -31.356 | -33.186 | -32.961 | -32.291 |
| EBITDA | 5.531 | 12.080 | 11.298 | 14.186 | 15.062 |
| Depreciation & amort. | -615 | -871 | -1.184 | -1.612 | -2.000 |
| EBIT | 4.916 | 11.209 | 10.114 | 12.574 | 13.062 |
| Net financials | -741 | -167 | -448 | -448 | -171 |
| Profit before tax | 4.175 | 11.042 | 9.666 | 12.126 | 12.891 |
| Tax | 933 | 2.407 | 2.116 | 2.680 | 2.846 |
| Net profit | 3.242 | 8.635 | 7.550 | 9.446 | 10.045 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 57.220 | 55.308 | 63.537 | 69.776 | 77.757 |
| Equity | 9.521 | 16.656 | 24.206 | 33.651 | 43.696 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 46.554 | 38.652 | 39.331 | 36.125 | 34.061 |
| Total debt | 46.554 | 38.652 | 39.331 | 36.125 | 34.061 |
EBITDA margin
31.8%
This company
15.8%
Market median
+101% vs market
20202024
Equity ratio
56.2%
This company
38.2%
Market median
+47% vs market
20202024
Return on equity
23.0%
This company
18.4%
Market median
+25% vs market
20202024
Net profit margin
21.2%
This company
8.1%
Market median
+162% vs market
20202024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JK Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (4) | ||
KN Management | Management | 2003 – 2004 |
LB Chief Executive Officer | Chief Executive Officer | 2015 – 2022 |
LS Management | Management | 2003 – 2003 |
MS Chief Executive Officer | Chief Executive Officer | 2011 – 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2022 | |
| Former (16) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2006 – 2007 | |
| Board of Directors | 2015 – 2018 | |
| Board of Directors | 2012 – 2018 | |
| Chairman | 2003 – 2006 | |
| Board of Directors | 2007 – 2010 | |
| Chairman | 2013 – 2022 | |
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2006 – 2007 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2007 – 2010 | |
| Board of Directors | 2003 – 2004 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2003 – 2006 | |
RI | Chairman | 2012 – 2013 |
| Board of Directors | 2006 – 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 | |
| Company | 10–14.99% | 10–14.99% | 2014 | |
| Company | 66.67–89.99% | 66.67–89.99% | 2017 | |
| Individual | 20–24.99% | 20% | 2022 | |
| Company | 10–14.99% | 10–14.99% | 2019 | |
| Company | 10–14.99% | 10–14.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LBN BidCo ApS
LBN MEDICAL ApS Board members of LBN MEDICAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karsten Nørholt | Management | 0 companies |
| Lars Braun Nielsen | Chief Executive Officer | 0 companies |
| Leif Staal | Management | 0 companies |
| Jesper Knud Nielsen | Chief Executive Officer | 0 companies |
| Mehdi Smaïl | Chief Executive Officer | 0 companies |
| Tanner LoRusso | Board of Directors | 0 companies |
| Bente Damgaard | Board of Directors | 0 companies |
| Jacob Møller Knudsen | Chairman | 0 companies |
| Gitte Havsager | Board of Directors | 0 companies |
| Jan Offersøy Nielsen | Board of Directors | 0 companies |
| John Larsen | Chairman | 0 companies |
| Ole Wallentin Bæk | Board of Directors | 0 companies |
| Per Schak Andreasen | Chairman | 0 companies |
| Frederik Reimer Jakobsen | Board of Directors | 0 companies |
| Lars Arendt-Nielsen | Board of Directors | 0 companies |
| Bradley William de Koning | Chairman | 0 companies |
| Jonathan Alan Spero | Board of Directors | 0 companies |
| Hans-Henrik Dose Stenild | Board of Directors | 0 companies |
| Jean André Bodart | Board of Directors | 0 companies |
| David Mendels Peterson | Board of Directors | 0 companies |
| Finn Løvfelt Frandsen | Board of Directors | 0 companies |
| Randi Ib | Chairman | 0 companies |
| Jan Brandrup | Board of Directors | 0 companies |